<DOC>
	<DOCNO>NCT00095030</DOCNO>
	<brief_summary>The purpose clinical research study learn whether muraglitazar-metformin combination least effective glimepiride-metformin combination treat type 2 diabetic sufficiently control metformin alone . The safety treatment also study .</brief_summary>
	<brief_title>Study Comparing Muraglitazar With Glimepiride Type 2 Diabetics Who Are Not Controlled With Metformin Alone</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Glimepiride</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Glycine</mesh_term>
	<criteria>Subject Type 2 diabetes receive treatment least 1,500 mg great 3000 mg stable metformin therapy least 6 week prior screen HbA1c &gt; = 7 % &lt; = 10 % Fasting cpeptide &gt; = 1.0 umol Body Mass Index &lt; = 41 kg/m2 Mean serum triglyceride &lt; = 600 mg/dl</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>Diabetes</keyword>
</DOC>